Brief: Tivic Health Systems Says Entered Amended License Agreement With Statera Biopharma - SEC Filing
25/06/2025 22:34
June 25 (Reuters) - Tivic Health Systems Inc TIVC.O: TIVIC HEALTH SYSTEMS INC - ON JUNE 18, ENTERED AMENDED LICENSE AGREEMENT WITH STATERA BIOPHARMA - SEC FILING TIVIC HEALTH SYSTEMS INC - A&R LICENSE AGREEMENT SUPERSEDES ORIGINAL LICENSE AGREEMENT - SEC FILING TIVIC HEALTH SYSTEMS - PURSUANT TO AMENDMENT, SUBSEQUENT PAYMENTS OF UP TO $5.6 MILLION TO BE PAID TO AVENUE CAPITAL - SEC FILING Source text: [ID:n0000950170-25-089981] Further company coverage: TIVC.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Valion Bio
See all newsBrief: Valion Bio Reports First Quarter 2026 Financial Results
Navigate FDA Submission
Brief: Tivic Health Systems Inc To Rebrand As Valion Bio, Ticker To Vbio Effective April 28, 2026
Brief: Tivic Health Systems Inc - Appoints Michael K. Handley As CEO And Board Member Effective March 3, 2026 - SEC Filing
Brief: Tivic Health Systems Enters Stock Purchase Agreement With Tumim Stone Capital